Log on / register
Feedback | Support | My details
Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer.
Han W, Han MR, Kang JJ, Bae JY, Lee JH, Bae YJ, Lee JE, Shin HJ, Hwang KT, Hwang SE, Kim SW, Noh DY
BMC Cancer 2006, 6:92
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
Microarray-based comparative genomic hybridisation of breast cancer patients receiving neoadjuvant chemotherapy.
Pierga JY, Reis-Filho JS, Cleator SJ, Dexter T, Mackay A, Simpson P, Fenwick K, Iravani M, Salter J, Hills M, Jones C, Ashworth A, Smith IE, Powles T, Dowsett M
Br J Cancer 2007 Jan 29, 96:341-51
[PubMed Central] [PubMed] [Related articles]

2.
Genomic signatures of breast cancer metastasis.
Urquidi V, Goodison S
Cytogenet Genome Res 2007, 118:116-29
[PubMed Central] [PubMed] [Related articles]

3.
Integrated analysis of copy number alteration and RNA expression profiles of cancer using a high-resolution whole-genome oligonucleotide array.
Jung SH, Shin SH, Yim SH, Choi HS, Lee SH, Chung YJ
Exp Mol Med 2009 Jul 31, 41:462-70
[PubMed Central] [PubMed] [Related articles]


This article is also cited by 2 articles in BioMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]

© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.